Latest News about NASH
Recent news which mentions NASH
CBG: The 'Mother Cannabinoid' May Hold Key To Treating Nonalcoholic Fatty Liver Disease Symptoms
January 23, 2023
Tickers
CBG
From Benzinga
CohBar Stock Edges Higher As Mitochondria Based Therapeutic Shows Encouraging Action In Early-Stage NASH Trial
August 11, 2021
Tickers
CWBR
From Benzinga
Galmed Stock Jumps As FDA Signs Off Use Of Aramchol Meglumine In Late Stage NASH Trial
August 02, 2021
Tickers
GLMD
From Benzinga
Theratechnologies In Search Of Potential Partner For Late-Stage NASH Study Of Tesamorelin, Reports Q2 Earnings
July 15, 2021
Tickers
THTX
From Benzinga
Akero's NASH Candidate Shows Substantial Liver Fat Reductions After Four Months Of Treatment
July 08, 2021
Tickers
AKRO
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.